Reata Pharmaceuticals Inc (RETA)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
J. Warren Huff
Employees:
123
2801 GATEWAY DRIVE SUITE 150, IRVING, TX 75063
972-865-2206

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its products include cardiovascular, rare diseases, immune-oncology, and ophthalmology. The company was founded by J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.

Data derived from most recent annual or quarterly report
Market Cap 759.119 Million Shares Outstanding31.473 Million Avg 30-day Volume 680.695 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-3.86
Price to Revenue420.0811 Debt to Equity0.0 EBITDA-256.628 Million
Price to Book Value9.7931 Operating Margin-2484.0186 Enterprise Value2.839 Billion
Current Ratio7.044 EPS Growth0.228 Quick Ratio6.8
1 Yr BETA 0.907 52-week High/Low 153.41 / 23.67 Profit Margin-3092.5436
Operating Cash Flow Growth-23.7435 Altman Z-Score3.0558 Free Cash Flow to Firm 18.244 Million
View SEC Filings from RETA instead.

View recent insider trading info

Funds Holding RETA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RETA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

16 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WORTLEY MICHAEL D CHIEF LEGAL OFFICER

  • Officer
105,000 2022-01-03 1

MCGAUGHY R KENT JR

399 2022-01-03 2

SONI MANMEET SINGH COO AND CFO

  • Officer
169,000 2022-01-03 2

EDWARDS MARTIN

  • Director
158 2022-01-03 2

MEYER COLIN JOHN CHIEF RESEARCH OFFICER

  • Officer
122,000 2022-01-03 2

RUFF SHAMIM

  • Director
317 2022-01-03 4

BIR DAWN CARTER CHIEF COMMERCIAL OFFICER

  • Officer
105,000 2022-01-03 1

MCCLELLAN WILLIAM D. JR.

  • Director
158 2022-01-03 2

ANAND BHASKAR VP, CHIEF ACCOUNTING OFFICER

  • Officer
41,500 2022-01-03 2

ROSE WILLIAM

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUP
5,810 2021-06-10 1

NIELSEN JACK

  • Director
6,201 2021-06-10 1

OLIGER CHRISTY J.

  • Director
5,180 2021-06-10 3

CASTELLANOS ELAINE VP, CHIEF ACCOUNTING OFFICER

  • Officer
57,414 2021-06-07 2

HUFF JAMES WARREN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
14,083 2021-01-04 0

CPMG INC

2,896,901 2020-12-23 0

BASS JAMES EDWARD

  • Director
0 2020-06-10 0

WILSON JASON DOUGLAS EXECUTIVE VP OF OPERATIONS

  • Officer
0 2020-01-02 0

TRAWEEK JAMES W JR

3,151,664 2019-12-30 0

ROSE WILLIAM

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

GALE CHARLES E.

CHARLES E. GALE FIDELITY ROLLOVER IRA

ROSE EVELYN P.

EVELYN P. ROSE FIDELITY ROLLOVER IRA

EVELYN POTTER ROSE SURVIVOR'S TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
1,099,583 2019-11-08 1

WARD KEITH WAYNE CHIEF DEVELOPMENT OFFICER

  • Officer
8,620 2019-02-25 0

ROSE WILLIAM

PUFFIN PARTNERS, L.P.

PUFFIN GP, LLC

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

GALE CHARLES E.

CHARLES E. GALE FIDELITY ROLLOVER IRA

ROSE EVELYN P.

EVELYN P. ROSE FIDELITY ROLLOVER IRA

EVELYN POTTER ROSE SURVIVOR'S TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
1,093,305 2018-11-13 1

ROSE WILLIAM

CHARLES HENRY ROSE 2001 TRUST

JOHN WILLIAM ROSE 2002 TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
1,093,305 2018-11-13 1

EVELYN POTTER ROSE SURVIVOR'S TRUST

  • 10% Owner
  • MEMBER OF A 10% OWNER GROUP
879,281 2018-11-13 0

ROSE WILLIAM

PUFFIN PARTNERS, L.P.

PUFFIN GP, LLC

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

GALE CHARLES E.

ESTATE OF EDWARD W. ROSE III

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUP
0 2017-12-07 1

ROSE WILLIAM

PUFFIN PARTNERS, L.P.

PUFFIN GP, LLC

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

GALE CHARLES E.

ESTATE OF EDWARD W. ROSE III

EVELYN POTTER ROSE SURVIVOR'S TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUP
0 2017-12-07 1

NOVO HOLDINGS A/S

  • 10% Owner
0 2017-06-22 0

ABBVIE INC.

  • 10% Owner
No longer subject to file 2017-03-28 0

STONE DENNIS K.

  • Director
0 2016-12-07 0

ROSE WILLIAM

ROSE EVELYN P.

EDWARD W. ROSE FIDELITY ROLLOVER IRA

EVELYN P. ROSE FIDELITY ROLLOVER IRA

GALE CHARLES E.

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
1,289,744 2016-08-18 0

STAPLETON PHARMA LLC

STAPLETON CRAIG R

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2016-06-09 0

ROSE WILLIAM

ESTATE OF EDWARD W. ROSE III

ROSE EVELYN P.

EDWARD W. ROSE FIDELITY ROLLOVER IRA

GALE CHARLES E.

CHARLES E. GALE FIDELITY ROLLOVER IRA

CHARLES HENRY ROSE 2001 TRUST

JOHN WILLIAM ROSE 2002 TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUP
1,101,114 2016-06-01 0

PUFFIN PARTNERS, L.P.

PUFFIN GP, LLC

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

  • 10% Owner
  • MEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUP
1,100,000 2016-06-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RUFF SHAMIM - Director

2022-01-05 16:04:26 -0500 2022-01-03 A 118 $27.32 a 118 direct -2.5458 -4.5146 0.0679 4 -4.5146 6

MCCLELLAN WILLIAM D. JR. - Director

2022-01-05 16:03:44 -0500 2022-01-03 A 59 $27.32 a 59 direct -2.5458 -4.5146 0.0679 4 -4.5146 6

ANAND BHASKAR - Officer VP, CHIEF ACCOUNTING OFFICER

2022-01-05 16:10:18 -0500 2022-01-03 A 25,000 a 25,000 direct

WORTLEY MICHAEL D - Officer CHIEF LEGAL OFFICER

2022-01-05 16:06:46 -0500 2022-01-03 A 35,000 a 35,000 direct -2.5458 -4.5146 0.0679 4 -4.5146 6

SONI MANMEET SINGH - Officer COO AND CFO

2022-01-05 16:07:48 -0500 2022-01-03 A 100,000 a 100,000 direct

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2022-01-05 16:08:33 -0500 2022-01-03 A 70,000 a 70,000 direct

EDWARDS MARTIN - Director

2022-01-05 16:02:19 -0500 2022-01-03 A 99 $16.14 a 99 direct

ANAND BHASKAR - Officer VP, CHIEF ACCOUNTING OFFICER

2022-01-05 16:10:18 -0500 2022-01-03 A 12,500 a 16,500 direct -2.5458 -4.5146 0.0679 4 -4.5146 6

BIR DAWN CARTER - Officer CHIEF COMMERCIAL OFFICER

2022-01-05 16:09:20 -0500 2022-01-03 A 70,000 a 70,000 direct

SONI MANMEET SINGH - Officer COO AND CFO

2022-01-05 16:07:48 -0500 2022-01-03 A 50,000 a 69,000 direct -2.5458 -4.5146 0.0679 4 -4.5146 6

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2022-01-05 16:08:33 -0500 2022-01-03 A 35,000 a 52,000 direct -2.5458 -4.5146 0.0679 4 -4.5146 6

EDWARDS MARTIN - Director

2022-01-05 16:02:19 -0500 2022-01-03 A 59 $27.32 a 59 direct -2.5458 -4.5146 0.0679 4 -4.5146 6

RUFF SHAMIM - Director

2022-01-05 16:04:26 -0500 2022-01-03 A 199 $16.14 a 199 direct

MCCLELLAN WILLIAM D. JR. - Director

2022-01-05 16:03:44 -0500 2022-01-03 A 99 $16.14 a 99 direct

BIR DAWN CARTER - Officer CHIEF COMMERCIAL OFFICER

2022-01-05 16:09:20 -0500 2022-01-03 A 35,000 a 35,000 direct -2.5458 -4.5146 0.0679 4 -4.5146 6

WORTLEY MICHAEL D - Officer CHIEF LEGAL OFFICER

2022-01-05 16:06:46 -0500 2022-01-03 A 70,000 a 70,000 direct

MCGAUGHY R KENT JR

2022-01-05 17:22:16 -0500 2022-01-03 A 399 $16.14 a 399 direct

SONI MANMEET SINGH - Officer COO AND CFO

2022-01-04 08:51:48 -0500 2021-12-31 P 16,000 $26.22 a 19,000 direct -4.9345 -1.0406 0.0 1 -4.9345 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
REATA PHARMACEUTICALS INC-A RETA 2022-01-28 14:45:03 UTC -0.2249 0.2949 350000
REATA PHARMACEUTICALS INC-A RETA 2022-01-28 14:15:03 UTC -0.2249 0.2949 350000
REATA PHARMACEUTICALS INC-A RETA 2022-01-28 13:45:03 UTC -0.2249 0.2949 350000
REATA PHARMACEUTICALS INC-A RETA 2022-01-28 13:15:03 UTC -0.2249 0.2949 350000
REATA PHARMACEUTICALS INC-A RETA 2022-01-28 12:45:03 UTC -0.2249 0.2949 350000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 22:15:03 UTC -0.2176 0.2876 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 21:45:03 UTC -0.2176 0.2876 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 21:15:03 UTC -0.2176 0.2876 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 20:45:03 UTC -0.2182 0.2882 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 20:15:04 UTC -0.2182 0.2882 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 19:45:03 UTC -0.2182 0.2882 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 19:15:03 UTC -0.2182 0.2882 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 18:45:03 UTC -0.2212 0.2912 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 18:15:03 UTC -0.2212 0.2912 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 17:45:03 UTC -0.2212 0.2912 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 17:15:03 UTC -0.2212 0.2912 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 16:45:03 UTC -0.2229 0.2929 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 16:15:03 UTC -0.2229 0.2929 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 15:45:02 UTC -0.2229 0.2929 300000
REATA PHARMACEUTICALS INC-A RETA 2022-01-27 15:15:03 UTC -0.2229 0.2929 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund RETA -4116.0 shares, $-330473.64 2019-09-30 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund RETA -12739.0 shares, $-1022814.31 2019-09-30 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund RETA -23.0 shares, $-3319.82 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund RETA -28.0 shares, $-4041.52 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund RETA -46.0 shares, $-4481.32 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund RETA -36.0 shares, $-5196.24 2020-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund RETA -13837.0 shares, $-1379548.9 2021-03-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund RETA -800.0 shares, $-113224.0 2021-06-30 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund RETA -1200.0 shares, $-120732.0 2021-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund RETA -3400.0 shares, $-342074.0 2021-09-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund RETA -906.0 shares, $-91152.66 2021-09-30 N-PORT
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund RETA -2409.0 shares, $-242369.49 2021-09-30 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio RETA -14900.0 shares, $-1499089.0 2021-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund RETA -158.0 shares, $-15896.38 2021-09-30 N-PORT
ETF Series Solutions- The Acquirers Fund RETA -3468.0 shares, $-332962.68 2021-10-31 N-PORT

Elevate your investments